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Review
Dichlorodiphenyltrichloroethane (DDT) is 
a potent insecticide that was used worldwide 
for agricultural and public health purposes 
from the 1940s until the 1970s, when concern 
about its toxic effects on wildlife and humans, 
its environmental persistence, and its concen-
tration in the food supply led to restrictions 
and prohibitions on its use [Agency for Toxic 
Substances and Disease Registry (ATSDR) 
2002]. Commercial mixtures, often called 
technical-grade DDT, contain two major iso-
mers, the active ingredient, p,p´-DDT, and a 
by-product, o,p´-DDT. DDT and its primary 
breakdown product, dichlorodiphenyldichloro-
ethylene (DDE), are highly lipophilic, per-
sist in the environment, and bioaccumulate in 
humans because of their long half-lives (6 years 
and possibly up to 10 years, respectively) 
(Longnecker 2005; Wolff et al. 2000).
DDT was identified as a potent insecticide 
in 1939 and was heavily used during World 
War II. After the war, DDT became the global 
insecticide of choice in households, for agri-
culture, and for public health vector-control 
projects. In 1962, Rachel Carson, in Silent 
Spring, noted that DDT bioaccumulates and 
biomagnifies up the food chain and raised con-
cerns that the pesticide may have long-lasting 
effects on wildlife and possibly on humans 
(Carson 1962).
In the United States, all nonpublic health 
uses of DDT were banned by 1972. Regulation 
by some other nations occurred more gradu-
ally. DDT continues to be used for malaria 
control in several African and Asian countries 
(Stockholm Convention on Persistent Organic 
Pollutants 2008). In 2001, more than 100 
countries signed the Stockholm Convention 
on Persistent Organic Pollutants (POPs), com-
mitting to eliminate the use of 12 POPs of 
greatest concern to the health of the global 
community, including DDT (United Nations 
Environment Programme 2001). By 2008, 
160 countries had ratified the Stockholm 
Convention, making it one of the most suc-
cessful inter national environmental agreements 
(Stockholm Convention on Persistent Organic 
Pollutants 2008). Recognizing the continued 
need for DDT use in some countries, the con-
vention allows the production and use of DDT 
for disease vector control only, provided that 
no safe, effective, and affordable alternatives 
are locally available. In these cases, the conven-
tion requires parties to notify the convention 
secretariat of their intention to produce and/
or use DDT for vector control and to prevent 
or minimize human exposure and release into 
the environment. In 2006, the World Health 
Organization (WHO) and the U.S. Agency for 
International Development (USAID) endorsed 
indoor DDT spraying to control malaria 
(WHO 2006).
On 14 March 2008, researchers met 
for the Eugene Kenaga International DDT 
Conference, which was jointly organized by 
the Pine River Superfund Citizen Task Force, 
the Center for Responsible Leadership, and 
the Public Affairs Institute of Alma College 
with the endorsement of the International 
Society of Environmental Epidemiology, 
the Society for Environmental Toxicology 
and Chemistry, Alma College, and the Pine 
River Superfund Task Force. The goal of the 
conference was to bring together experts on 
DDT and concerned citizens to address the 
current and legacy implications of DDT pro-
duction and use. This conference was held 
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oBjectives: Dichlorodiphenyltrichloroethane (DDT) was used worldwide until the 1970s, when 
concerns about its toxic effects, its environmental persistence, and its concentration in the food sup-
ply led to use restrictions and prohibitions. In 2001, more than 100 countries signed the Stockholm 
Convention on Persistent Organic Pollutants (POPs), committing to eliminate the use of 12 POPs 
of greatest concern. However, DDT use was allowed for disease vector control. In 2006, the World 
Health Organization and the U.S. Agency for International Development endorsed indoor DDT 
spraying to control malaria. To better inform current policy, we reviewed epidemiologic studies 
published from 2003 to 2008 that investigated the human health consequences of DDT and/or 
DDE (dichlorodiphenyldichloroethylene) exposure.
data sources and extraction: We conducted a PubMed search in October 2008 and retrieved 
494 studies.
data synthesis: Use restrictions have been successful in lowering human exposure to DDT, but 
blood concentrations of DDT and DDE are high in countries where DDT is currently being used 
or was more recently restricted. The recent literature shows a growing body of evidence that expo-
sure to DDT and its breakdown product DDE may be associated with adverse health outcomes 
such as breast cancer, diabetes, decreased semen quality, spontaneous abortion, and impaired neuro-
development in children.
conclusions: Although we provide evidence to suggest that DDT and DDE may pose a risk to 
human health, we also highlight the lack of knowledge about human exposure and health effects in 
communities where DDT is currently being sprayed for malaria control. We recommend research 
to address this gap and to develop safe and effective alternatives to DDT.
key words: DDE, DDT, dichlorodiphenyldichloroethylene, dichlorodiphenyltrichloroethane, health 
effects, organochlorine pesticides, persistent organic pollutants. Environ Health Perspect 117:1359–1367 
(2009). doi:10.1289/ehp.11748 available via http://dx.doi.org/  [Online 4 May 2009]
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at Alma College, near the Velsicol Chemical 
Corporation U.S. Superfund site in Gratiot 
County, Michigan.
The purpose of this review is to summa-
rize information on health risks so as to bet-
ter inform risk–benefit analyses and policy. 
We do so by reviewing evidence of human 
exposure to DDT and some of its potential 
health consequences, focusing primarily on 
studies that have been published since the 
endorsement of DDT by WHO and USAID 
and since the publication of other literature 
reviews on the subject (Longnecker 2005; 
Rogan and Chen 2005). We conducted 
a search of PubMed (National Library of 
Medicine, Bethesda, MD, USA) to find 
human studies (excluding case reports) pub-
lished in English from 2003 to 2008 by using 
the following search terms: (DDT OR DDE) 
AND (toxicity OR health OR cancer OR car-
cinogenicity OR reproduction OR estrogen 
OR neurological OR development OR expo-
sure OR diabetes OR pregnancy OR mis-
carriage OR spontaneous abortion OR birth 
weight OR gestation OR lactation OR birth 
defects OR growth OR puberty OR fertility 
OR neurotoxicity OR neurodevelopment OR 
immunological). We identified 494 papers 
and reviewed them for primary research. 
On the basis of available data, we make rec-
ommendations regarding the introduction, 
continuation, or reintroduction of DDT use 
worldwide. These recommendations repre-
sent the consensus opinion of the authors and 
participants present at the Eugene Kenaga 
International DDT Conference.
Potential for Human Exposure
Environmental and biological monitoring 
studies in the United States demonstrate 
that use restrictions were successful in low-
ering human exposure to DDT. Estimated 
dietary intake of DDT dropped > 200% 
between 1970 and 1986 (ATSDR 2002), 
whereas serum DDT concentrations declined 
9-fold between 1980 and 2000 [Centers 
for Disease Control and Prevention (CDC) 
2003; Murphy et al. 1983]. Recent studies 
in the United States report low concentra-
tions of DDT and DDE in food (U.S. Food 
and Drug Administration 2002) and in house 
dust and soil (Bradman et al. 1997; Butte 
and Heinzow 2002). Yet nearly all U.S. resi-
dents have measurable serum p,p´-DDE lev-
els, whereas p,p´-DDT is detected in 5–10% 
of the population (CDC 2005).
A sample of recent studies of DDT/DDE 
serum levels in pregnant women and women 
of reproductive age shows the different expo-
sure scenarios around the world. In this 
sample of studies, low concentrations were 
observed in U.S. women of reproductive age 
participating in the 2001–2002 wave of the 
National Health and Nutrition Examination 
Survey (NHANES; Table 1). The median 
DDE serum concentration was 10-fold 
higher in a population of primarily Mexican 
immigrant women living in an agricultural 
area of California where half of the women 
had immigrated within the previous 5 years 
(Bradman et al. 2007). DDE concentrations 
in this Mexican-American cohort were similar 
to those of a concurrent population living 
in Morelos, Mexico, where DDT probably 
had not been used for some time (Torres-
Sanchez et al. 2007). However, median DDE 
serum concentrations in women residing in 
Chiapas, Mexico, where DDT may have been 
used up until 2000, were about five times 
higher in 1998 (Koepke et al. 2004) than in 
Morelos (Torres-Sanchez et al. 2007) and 
within the range observed in older studies 
from the United States when DDT was still 
being used (Bhatia et al. 2005; Gladen et al. 
2004; Longnecker et al. 2005). However, the 
concentrations in pregnant women in Chiapas 
are still orders of magnitude lower than those 
reported in a study of South African men 
whose houses were sprayed with DDT as part 
of indoor residual spraying programs (mean 
blood DDE concentration = 239 ± 215 µg/g 
lipid) (Aneck-Hahn et al. 2007). Other stud-
ies conducted in South Africa also reported 
very high levels of DDT/DDE in breast milk 
(Bouwman et al. 1994, 2006). It may be 
that the pattern of use and/or formulation of 
DDT for malaria control differed in Chiapas 
and South Africa. Nevertheless, these data 
suggest that indoor residual spraying results 
in high DDT exposure in humans, includ-
ing vulnerable populations, such as pregnant 
women and fetuses.
Evidence for Carcinogenicity 
and Cancer in Humans
In 1991, the International Agency for Research 
on Cancer (IARC) rated DDT as “possibly 
carcinogenic to humans (Group 2B)” (IARC 
1991). This rating was largely based on the 
induction of liver tumors in experimental 
animal studies that reported significant 
increases in hepatomas (neoplastic liver cell 
tumors) in multiple strains of male and female 
rodents exposed to technical DDT orally (gav-
age or diet) or to p,p´-DDE (diet) (IARC 
1991). Most human studies reviewed by 
IARC in 1991 did not show an association 
between DDT exposure and cancer risk. Some 
studies suggested that DDT exposure may be 
associated with certain cancers (lung cancer 
and lymphomas); however, the lack of control 
for exposure to other chemicals, small study 
size, insufficient data on confounding factors 
(e.g., incomplete information on tobacco use), 
and short follow-up time for long-latency can-
cers limited the ability to make any conclu-
sions at that time (IARC 1991). Research on 
DDT/DDE exposure and cancer continued to 
yield mixed results after the publication of the 
IARC report. We review the recent research 
with a focus on cancers of the liver, pancreas, 
and breast.
Table 1. Median p,p´-DDE and p,p´-DDT serum concentrations in pregnant women or women of repro-
ductive age from various study populations.
Location Years
p,p´-DDE
(µg/g lipids)
p,p´-DDT
(ng/g lipids) Reference
Canada, Nunavik 1994–1997 0.2a 15a Van Oostdam et al. 2004
Canada, Kitikmeot 1994–1997 0.1a 8.3a Van Oostdam et al. 2004
China, Anhui Province 1996–1998 5.9b — Perry et al. 2005
Finland 1994–1997 0.06a 2.4a Van Oostdam et al. 2004
Greenland 1994–1997 0.4a 26a Van Oostdam et al. 2004
Greenland 2002–2003 0.3 — Jonsson et al. 2005
Iceland 1994–1997 0.1a 4a Van Oostdam et al. 2004
Mexico, Chiapas 1998 4.8 676 Koepke et al. 2004
Mexico, Chiapas 2002–2003 2.7 250 Longnecker et al. 2007
Mexico, Morelos 2001–2005 1.0a,c — Torres-Sanchez et al. 2007
Mexico, Oaxaca 2000 8.0a 3,140a Barraza-Vazquez et al. 2008
Norway 1994–1997 0.1a 3a Van Oostdam et al. 2004
Poland, Warsaw 2003–2004 0.4 — Jonsson et al. 2005
Poland, Wielkopolska 2004 0.3 20.2 Jaraczewska et al. 2006
Russia 1994–1997 0.4a 48a Van Oostdam et al. 2004
Spain NR 4b,c 1,330b,c Jimenez Torres et al. 2006
Sweden 1994–1997 0.1a 2.4a Van Oostdam et al. 2004
Sweden, Uppsala County 1996–1999 0.01b 5b Glynn et al. 2007
Sweden 2002–2003 0.1 — Jonsson et al. 2005
Ukraine, Kharkiv 2002–2004 0.7 — Jonsson et al. 2005
USA, Philadelphia, PA 1959–1965 5.7 1,900 Gladen et al. 2004
USA, Multicenter 1959–1965 3.2c — Longnecker et al. 2005
USA, California 1959–1967 2.2 2,000 Bhatia et al. 2005
USA, Alaska 1994–1997 0.1a 3.7a Van Oostdam et al. 2004
USA, California 1999–2000 1.1 12.5 Bradman et al. 2007
U.S. representative sample 2001–2002 0.1 < 17.4 CDC 2005
Abbreviations: —, not measured; NR, not reported. 
aGeometric mean. bArithmetic mean. cCalculated assuming third-trimester serum lipid levels of 7.9 g/L (Longnecker et al. 2003).
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Liver cancer. In an ecologic study, Cocco 
et al. (2000) found that standardized mortality 
rates (SMRs) for liver cancer were elevated in 
whites but not in African Americans who lived 
in states with high population-level adipose 
tissue DDE concentrations. These researchers 
offered no explanation for this racial differ-
ence. In a case–control study, McGlynn et al. 
(2006) reported that the risk of liver cancer 
was significantly elevated in Chinese men with 
the highest blood levels of DDT [odds ratio 
(OR) = 3.8; 95% confidence interval (CI), 
1.7–8.0] compared with men with lower levels 
of DDT. Blood levels of DDE were not asso-
ciated with a higher risk.
Pancreatic cancer. Mechanistic data sug-
gest that DDT could play a role in pancreatic 
cancer by modulating activation of the onco-
gene K-ras (Porta et al. 1999). An association 
of workplace exposure to DDT and the risk 
of pancreatic cancer is supported by two stud-
ies. In a cohort of 5,886 DDT manufactur-
ing plant workers, Garabrant et al. (1992) 
reported a 7.4-fold higher risk of pancreatic 
cancer deaths in workers exposed to DDT for 
an average of 47 months, as determined using 
work records and interviews with coworkers, 
compared with workers who had no exposure. 
Similarly, deaths from pancreatic cancer were 
significantly higher in a cohort occupationally 
exposed to DDT compared with a control 
cohort in an Australian study with follow-up 
data from 1935 to the 1990s (SMR = 3.57; 
95% CI, 1.09–15.40) (Beard et al. 2003). In 
contrast, other studies have found no asso-
ciation between estimates of DDT exposure 
among workers (Cocco et al. 2005) or serum/
adipose tissue levels of p,p´-DDE and pancre-
atic cancer risk after adjustment for confound-
ers (Hardell et al. 2007; Hoppin et al. 2000). 
It has been suggested that the etiology of pan-
creatic cancer may be causally linked to diabe-
tes mellitus and hyperinsulinemia (Michaud 
2004) and thus linked to associations between 
DDT and diabetes (see below).
Breast cancer. Although neither DDT nor 
DDE induced mammary tumors in labora-
tory animal cancer bioassays (IARC 1991), 
early studies suggested that DDE levels in 
women were associated with a higher risk of 
breast cancer (Snedeker 2001). Two recent 
case–control studies (Charlier et al. 2004; 
Rubin et al. 2006) also showed higher DDE 
blood concentrations in cases than controls. 
However, most case–control studies recently 
published and reviewed have not supported 
an association (Brody et al. 2004; Gatto et al. 
2007; Ibarluzea et al. 2004; Iwasaki et al. 
2008; Lopez-Cervantes et al. 2004; Siddiqui 
et al. 2005; Snedeker 2001).
The literature on DDT and breast cancer 
has two main limitations. First, most studies 
used biological samples collected well after 
exposure to technical DDT had occurred and 
relied on serum concentrations of p,p´-DDE as 
a proxy for exposure to “DDT.” Second, most 
studies included women who would not have 
been exposed to technical DDT when young, 
yet both animal (Birnbaum and Fenton 2003) 
and human studies of radiation exposure 
(Howe and McLaughlin 1996; Tokunaga 
et al. 1994) strongly suggest that the breast is 
most vulnerable to environmentally induced 
carcinogenesis during several critical periods 
such as in utero, before menarche, and before 
first pregnancy.
Overcoming these past limitations, Cohn 
et al. (2007) measured concentrations in 
archived serum samples collected between 
1959 and 1967 (peak years of DDT use) from 
pregnant women participating in the Child 
Health and Development Studies (CHDS). 
Medical records were obtained nearly 40 years 
later. Among women who were ≤ 14 years of 
age by 1945 (when DDT was first introduced 
for use by the general public), those with 
blood concentrations in the highest tertile 
were five times more likely to develop breast 
cancer than those with blood levels in the 
lowest tertile (OR = 5.4; 95% CI, 1.7–17.1). 
However, there was no association between 
serum p,p´-DDT levels and adult risk of 
breast cancer among women who were not 
exposed before 14 years of age, and interac-
tion by age in 1945 was statistically signifi-
cant. This study suggests that the prepubertal 
and pubertal years are critical periods of expo-
sure. Thus, previous studies that measured 
exposure in older women may have missed 
the critical period.
Other cancers. Research has not sup-
ported an association of DDT or DDE and 
incidence of colorectal, lung, bladder, pros-
tate, endometrial, and stomach cancers (Baris 
et al. 1998; Cocco et al. 2005; Hardell et al. 
2004; Howsam et al. 2004; Purdue et al. 2007; 
Sturgeon et al. 1998; Weiderpass et al. 2000). 
Although no associations were found with 
serum DDT (Rothman et al. 1997), higher 
DDE levels in dust, adipose tissue, and plasma 
have been associated with non-Hodgkin lym-
phoma in case–control studies (Colt et al. 
2005; Quintana et al. 2004; Spinelli et al. 
2007). For other cancers, such as leukemia 
(Flodin et al. 1988; Purdue et al. 2007), and 
testicular cancer (Hardell et al. 2006; McGlynn 
et al. 2008), evidence remains equivocal.
Evidence for Diabetes
Since Morgan et al.’s (1980) initial observa-
tion that the sum of DDT and DDE levels 
in serum was 29% higher in occupationally 
exposed workers with diabetes compared with 
nondiabetics, a number of other studies have 
been published on this subject. For example, 
data from the 1999–2002 NHANES sug-
gested that elevated serum concentrations of 
p,p´-DDT (Everett et al. 2007) and p,p´-DDE 
(Lee et al. 2006) were significantly associ-
ated with the prevalence of diabetes. In addi-
tion, Lee et al. (2006) reported an increasing 
trend in the odds of diabetes as exposure to 
p,p´-DDE increased (ptrend < 0.001) with 
an OR of 4.3 (95% CI, 1.8–10.2) for those 
≥ 90th percentile of exposure compared with 
those in the lowest quartile.
Because diabetes occurs in Mexican 
Americans twice as frequently as in non- 
Hispanic whites (Haffner 1998), and serum 
levels of p,p´-DDE and p,p´-DDT are higher 
in Mexican Americans than other ethnic 
groups in the U.S. population (CDC 2001), 
data from the Hispanic Health and Nutrition 
Examination Survey (HHANES) for 1982–
1984 were analyzed. Serum p,p´-DDT or 
p,p´-DDE levels were dose related to the 
preva lence of self-reported diabetes in Mexican 
Americans (Cox et al. 2007). Additionally, in a 
study of Native Americans (Mohawks), Codru 
et al. (2007) observed a significant positive 
association between diabetes prevalence and 
serum levels of p,p´-DDE.
A Swedish study found that diabetes preva-
lence was significantly higher (ptrend = 0.04) in 
Baltic Sea fishermen with elevated serum DDE 
levels (Rylander et al. 2005), but not in their 
wives. With a larger study population (non-
fisherman families), the same authors reported 
a significant positive association (ptrend < 0.01) 
between type 2 diabetes and serum p,p´-DDE 
levels in Swedish women (Rignell-Hydbom 
et al. 2007).
Collectively, these studies from the United 
States and Sweden suggest that body burdens 
of DDT and/or DDE may be associated with 
the prevalence of diabetes. A variety of other 
persistent environmental chemicals also have 
been associated with diabetes prevalence (Lee 
et al. 2006). However, given the high correla-
tion among various organochlorine exposures 
(Bradman et al. 2007), additional research is 
needed to delineate the specific contributions 
of DDT and DDE.
Evidence for Health 
Consequences to the Fetus
Pregnancy loss. In the U.S. Collaborative 
Perinatal Project (CPP), where the median 
maternal serum DDE level was 24.5 µg/L, 
high DDE concentrations (45–59 vs. 
< 15 µg/L) were associated with an increased 
risk of fetal loss in previous pregnancies 
(Longnecker et al. 2005). Although the out-
come occurred before DDE measurement, 
this study of 1,717 women corroborated find-
ings from smaller studies (Korrick et al. 2001; 
Saxena et al. 1981). Venners et al. (2005) 
studied 338 nulliparous Chinese textile work-
ers with similar DDE concentrations (median, 
29 ng/g serum) for the risk of early pregnancy 
loss (measured by daily human chorionic 
gonadotropin). Authors reported an OR of 
Eskenazi et al.
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1.17 (95% CI, 1.05–1.29) for each 10-ng/g 
serum increase in total DDT. In a case– 
control study of habitual aborters, research-
ers did not observe higher mean serum DDE 
levels in cases relative to controls (Sugiura-
Ogasawara et al. 2003).
Gestational length and birth weight. 
Early studies on DDE and preterm delivery 
(< 37 weeks of gestation) were small, and 
results were inconsistent (Berkowitz et al. 
1996; O’Leary et al. 1970; Saxena et al. 1981; 
Wassermann et al. 1982). Studies using data 
from larger cohorts also have not consistently 
supported an association between exposure to 
DDT/DDE and birth weight or gestational 
duration. In a study of 2,380 pregnant women 
participating in the CPP, Longnecker et al. 
(2001) found that the odds of preterm delivery 
were 3.1 times higher (95% CI, 1.8–5.4) in 
women with serum DDE ≥ 60 µg/L compared 
with those with DDE < 15 µg/L during preg-
nancy. Adjusted odds of having a child small 
for gestational age also increased, but less con-
sistently (ptrend = 0.04). However, two analyses 
of the CHDS, which was conducted around 
the same time as the CPP, have found no asso-
ciations of DDT/DDE and preterm delivery 
or small for gestational age, despite slightly 
higher median DDE levels than in the CPP 
(43 vs. 25 µg/L) (Farhang et al. 2005; Jusko 
et al. 2006).
Most studies of more recent cohorts, 
which had somewhat lower exposure than 
those in the earlier studies, did not find an 
association between maternal serum meas ure-
ments of DDE and/or DDT and gestational 
duration, premature labor, birth weight, 
or other measures of fetal growth such as 
crown–heel length or head circumference 
(Bjerregaard and Hansen 2000; Fenster et al. 
2006; Gladen et al. 2003; Karmaus and Zhu 
2004; Khanjani and Sim 2006; Sagiv et al. 
2007; Wood et al. 2007), although some 
studies did find associations (Siddiqui et al. 
2003; Weisskopf et al. 2005; Wolff et al. 
2007). The high DDE serum concentrations 
observed in the CPP and CHDS cohorts 
during the 1960s are several-fold higher than 
current serum levels, but substantially lower 
than in populations where indoor residual 
spraying is occurring.
Duration of lactation. Two studies 
have found a shorter duration of lactation 
among mothers with high breast milk DDE 
concentrations (Gladen and Rogan 1995; 
Rogan et al. 1987). A North Carolina study 
of 858 women indicated that higher breast 
milk DDE concentrations were associated 
with a shorter median duration of lactation 
(2.5 months for DDE > 6 µg/g lipids vs. 6.5 
months for DDE < 1 µg/g lipids) (Rogan et al. 
1987). A study of 229 Mexican women found 
similar results (Gladen and Rogan 1995), 
but only among women who had previously 
lactated. Estrogenic effects of DDT were pos-
tulated to affect prolactin levels and milk pro-
duction (Gladen and Rogan 1995; Rogan 
et al. 1987). A more recent study suggested 
that DDE serum concentrations were related 
to decreased rates of breast-feeding initiation 
as well as shortened duration of lactation in 
women who had never breast-fed and in non-
smoking women (Karmaus et al. 2005b), but 
a Mexican study found that serum DDE was 
associated with duration of lactation only in 
women who previously breast-fed (Cupul-
Uicab et al. 2008). In this Mexican study of 
784 mothers of male term babies, the hazard 
ratio of weaning for women with high serum 
DDE levels (cutoff point, 9 µg/g lipids) was 
1.76 (95% CI, 1.22–2.53) in women who 
had previously breast-fed and 0.91 (95% CI, 
0.66–1.26) in women who had never breast-
fed. Previous lactation can reduce the mater-
nal body burden of DDE, and women who 
breast-feed longer for previous infants tend to 
do so for the current baby. Thus, associations 
between DDE levels and early weaning may 
be spurious, and further research is warranted.
Urogenital birth defects. Studies in rats 
have suggested a relationship between fetal tis-
sue concentrations of 10–20 ppm of p,p´-DDE 
and reproductive abnormalities in male off-
spring (Gray et al. 2001). In the CPP birth 
cohort, Longnecker et al. (2002) reported ORs 
of 1.07 (95% CI, 0.97–1.18) for cryptorchid-
ism (n = 219), 1.01 (95% CI, 0.90–1.14) for 
hypospadias (n = 199), and 1.06 (95% CI, 
0.97–1.16) for polythelia (n = 167) for each 
2.67 µg/g lipid increase in maternal serum 
p,p´-DDE (Longnecker et al. 2002). However, 
in the CHDS birth cohort, Bhatia et al. (2005) 
found that the odds of cryptorchidism were 
twice as high in participants with p,p´-DDT 
levels above versus below the median (OR = 
1.97; 95% CI, 1.40–2.54) but found no asso-
ciations between maternal serum p,p´-DDE 
and the odds of cryptorchidism, or between 
p,p´-DDT and p,p´-DDE concentrations and 
odds of hypospadias. A Spanish study also 
reported more than a doubling of the odds of 
cryptorchidism and/or hypospadias cases asso-
ciated with detectable levels of p,p´-DDT (OR 
= 2.63; 95% CI, 1.21–5.72) and o,p´-DDT 
(OR = 2.25; 95% CI, 1.03–4.89) measured in 
placental tissues (Fernandez et al. 2007). Other 
studies conducted in France (Brucker-Davis 
et al. 2008) and in Finland and Denmark 
(Damgaard et al. 2006) reported increased 
colostrum levels of p,p´-DDE, and elevated 
breast milk concentrations of p,p´-DDT, 
o,p´-DDT, p,p´-DDE, and p,p´-dichloro-
diphenyldichloroethane (DDD), respectively, 
in cases of cryptorchidism compared with 
 controls, although associations were not statis-
tically significant.
Child growth. Evidence for an association 
between physical growth after birth and DDT 
and DDE exposure is inconsistent. Maternal 
DDT concentrations were not associated with 
child weight or height at 5 years of age in 
children participating in the CHDS (Jusko 
et al. 2006). In contrast, those who had the 
highest prenatal concentrations of DDE in 
the CPP cohort (≥ 60 µg/L) compared with 
the lowest (< 15 µg/L) were significantly 
shorter at 1, 4, and 7 years of age (Ribas-Fito 
et al. 2006a). However, a study that examined 
growth in adolescent boys participating in 
the CPP found no relation between mater-
nal serum levels of DDE or DDT in preg-
nancy and height, body mass index (BMI), 
and other measures of growth (Gladen et al. 
2004). Two other studies in older children 
and in populations with much lower serum 
levels reported conflicting findings: A study 
from Germany found shorter height in 
8-year-old girls in relation to higher DDE 
concentration (Karmaus et al. 2002), and an 
older North Carolina study found a relation 
to taller height in boys 12–14 years of age 
(Gladen et al. 2000). Overall, the evidence for 
the relation of maternal DDT exposure and 
child physical growth is weak.
Evidence for Reproductive 
Effects
Age of onset of puberty. A small number of 
human studies have examined DDT/DDE 
and onset of menarche in girls, with two 
studies finding associations of earlier age at 
menarche with higher exposure (Ouyang 
et al. 2005; Vasiliu et al. 2004) and one study 
finding no association (Denham et al. 2005). 
Ouyang et al. (2005) found that women with 
higher serum levels of total DDT (i.e., the 
sum of p,p´- and o,p´-isomers of DDT, DDE, 
and DDD) measured in adulthood (mean 
age, 24.9 years) reported significantly earlier 
age at onset of menarche, adjusting for BMI 
and birth year. In contrast, Denham et al. 
(2005) found no association between concur-
rent DDE blood concentrations [geometric 
mean (GM) = 0.35 ppb] and menarcheal sta-
tus among 138 Mohawk girls 10–16.9 years 
of age. Vasiliu et al. (2004) estimated serum 
DDE levels during pregnancy in 151 women 
by back-calculating from measurements made 
up to 25 years later. They reported that higher 
(estimated) prenatal DDE levels were associ-
ated with earlier age at menarche in daughters 
(adjusted β = –0.07, p = 0.04).
Two studies examined onset of puberty 
rather than menarche in relation to DDE 
exposure. Gladen et al. (2000) found no asso-
ciation between transplacental or lactational 
DDE concentrations and pubertal stage as 
self-reported in a cohort of approximately 315 
adolescent girls with relatively high exposure 
(range, 0.3–25.8 ppm). Wolff et al. (2008) 
performed Tanner exams on approximately 
80 9-year-old girls and found no difference in 
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concurrent DDE plasma levels in those girls 
who had reached Tanner breast stage 2 (onset 
of puberty) and those who did not, but DDE 
levels were low. Only one study has exam-
ined onset of puberty in boys. Gladen et al. 
(2000) found no association between DDE 
and self-reported Tanner staging in boys up 
to 16 years of age. All these studies examined 
associations with DDE and not DDT.
Although these studies of puberty and 
menarche suggest an association with expo-
sure, no study has examined the relationship 
of serum levels of DDE and DDT concen-
trations in blood collected before puberty in 
relation to Tanner staging in girls or boys.
Male fertility. Researchers have investi-
gated the seminal parameters of men living in 
regions of high DDT use. In one such study 
(de Jager et al. 2006), participants were drawn 
from rural communities in the malaria-en-
demic region of Chiapas, Mexico, with a his-
tory of high use and where DDT was sprayed 
inside their homes at least annually from the 
late 1940s until 1997 (Stapleton 1998); sam-
pling took place between 2000 and 2001. 
The mean serum DDE concentration (45 ± 
31 µg/g lipids) was 100 times higher than 
reported in unexposed populations. The per-
centage of motile sperm was negatively cor-
related with plasma DDE concentrations, 
whereas the percentage of sperm with mor-
phologic tail defects and insufficient sperm 
chromatin condensation was positively corre-
lated with these levels (de Jager et al. 2006).
In a study conducted in Limpopo, South 
Africa, men were selected from rural com-
munities in a malaria-endemic area where 
DDT is sprayed annually inside unpainted 
houses, but not inside painted houses (Aneck-
Hahn et al. 2007). The GM serum concentra-
tions of DDT (90.2 ± 102.4 µg/g) and DDE 
(215.5 ± 210.6 µg/g) in the 311 participants 
from this area were extremely high. DDT 
and DDE serum concentrations were also 
significantly higher (p < 0.001) in partici-
pants whose houses were sprayed with DDT 
(101.9 µg/g lipid DDT and 239.0 µg/g lipid 
DDE) compared with those whose houses 
were not sprayed (30.5 µg/g lipid DDT and 
99.5 µg/g lipid DDE). Their semen volume 
was low (1.9 ± 1.3 mL) and several sperm 
motion parameters were impaired, includ-
ing the percentage of motile sperm in men 
with higher DDT (r = –0.27, p < 0.001) and 
DDE concentrations (r = –0.20, p < 0.001). 
In another cross-sectional study of 48 DDT 
applicators (Dalvie et al. 2004) conducted in 
Limpopo, overall semen quality was low, and 
DDT, but not DDE, serum levels were asso-
ciated with decreased sperm count.
Studies of semen quality or genetic mark-
ers in sperm have been conducted in other 
populations, usually with lower exposure 
than noted in Chiapas or South Africa. For 
example, case–control studies of men of sub-
fertile couples have found no difference in 
the men’s DDE serum levels (Charlier and 
Foidart 2005) but higher current blood levels 
in the mothers of the cases compared with 
controls, and no association with DNA integ-
rity (neutral comet assay) (Hauser et al. 2003). 
Similarly, the multinational (Greenland; 
Warsaw, Poland; Kharkiv, Ukraine; and 
Sweden) INUENDO study of European and 
Inuit pregnant women and their spouses failed 
to find associations of DDE serum levels and 
conventional measures of semen quality (Toft 
et al. 2006), chromatin integrity (Spano et al. 
2005), and hormone levels or a measure of 
apoptosis (Stronati et al. 2006). However, 
as in many populations where exposure to 
several organochlorines, including polychlo-
rinated biphenyls, may be highly correlated, 
independent associations with DDE often 
could not be established.
Overall, studies of highly exposed pop-
ulations suggest that male fertility may be 
adversely affected by DDT exposure, but 
studies in populations with moderate to low 
exposure levels do not support a relationship 
between exposure and male fertility outcomes.
Female reproduction, fertility, and time to 
conception. Two recent studies examined the 
relationship of DDT/DDE levels and men-
strual cycle characteristics and found only 
weak associations (Chen et al. 2005; Cooper 
et al. 2005). However, one study from the 
INUENDO population reported a 3-fold 
increase in risk of long menstrual cycles 
among Polish women but not among women 
from other European countries (Toft et al. 
2008). Another study using data from the 
Hispanic Health and Nutrition Examination 
Survey found that both DDT and DDE lev-
els were associated with a significantly earlier 
age of menopause (Akkina et al. 2004).
Two cross-sectional studies found sug-
gestive evidence that p,p´-DDE serum lev-
els in pregnant women were correlated with 
delays in conception (Axmon et al. 2006; Law 
et al. 2005), but another study in Mexican-
American women did not find a relation with 
either p,p´-DDT or p,p´-DDE serum levels 
(Harley et al. 2008). One of these studies 
(Axmon et al. 2006) also examined paternal 
serum p,p´-DDE and found no effects on 
partners’ time to pregnancy. In contrast, a 
study of 105 male DDT applicators found 
that p,p´-DDE exposure, estimated by occu-
pation history, was associated with delayed 
time to pregnancy in their spouses, defined 
using marriage dates and birth dates of first-
born children (Cocco et al. 2005).
The only study to examine in utero expo-
sure to DDT and time to pregnancy was con-
ducted among 289 women born in California 
between 1960 and 1963 (CHDS). Authors 
found that each 10-µg/L increase in mothers’ 
serum concentrations of p,p´-DDT and 
p,p´-DDE during pregnancy was associated 
with a 32% reduction and a 16% increase, 
respectively, in their daughters’ per cycle 
probability of pregnancy (Cohn et al. 2003). 
The ratio of these two compounds varied 
considerably, and longer time to pregnancy 
in daughters was observed as the ratio of 
p,p´-DDT to p,p´-DDE increased in maternal 
serum samples. Findings suggest that recent 
exposure or direct exposure to the pesticide, 
rather than chronic exposure to p,p´-DDE in 
the food chain, was the underlying risk factor.
Overall, the few studies conducted to date 
suggest that DDT exposure may affect time 
to pregnancy, but more research is needed.
Evidence for 
Neurodevelopmental Effects
DDT exerts its insecticidal effects by dis-
rupting the nervous system. Animal studies 
confirm that DDT is a neurodevelopmental 
toxicant (ATSDR 2002). In mice, exposure 
to DDT timed to sensitive periods of pre-
natal (Craig and Ogilvie 1974) and neonatal 
(Eriksson and Nordberg 1986; Eriksson et al. 
1990; Johansson et al. 1996) nervous sys-
tem development has been shown to cause 
behavioral and neurochemical changes into 
adulthood.
The few studies conducted in humans have 
focused primarily on exposure to DDE rather 
than DDT. In a North Carolina birth cohort 
recruited in the 1980s, Rogan et al. (1986) 
reported that maternal serum and breast milk 
DDE levels were related to hyporeflexia in a 
dose-dependent fashion in infants assessed by 
the Brazelton Neonatal Behavioral Assessment 
Scale (BNBAS), but this finding has not been 
replicated in more recent studies (Engel et al. 
2007; Fenster et al. 2006; Stewart et al. 2000). 
In a recent investigation from Massachusetts, 
DDE measured in cord blood was negatively 
related to BNBAS measures of alertness and 
attention and positively related to measures of 
irritability, although only the trend for irrita-
bility was significant (Sagiv et al. 2008).
The North Carolina study reported no 
adverse association between perinatal DDE 
exposure and performance on the Bayley 
Scales of Infant Development (BSID) from 
6 to 24 months of age (Gladen et al. 1988; 
Rogan and Gladen 1991); on the McCarthy 
Scales of Children’s Abilities (MCSA) at ages 
3, 4, and 5 years; or on school performance 
at 8–10.5 years (Gladen and Rogan 1991). 
Similarly, a study conducted in Oswego, 
New York, found no association of DDE lev-
els and performance on the Fagan Test of 
Infant Intelligence at 6 and 12 months of 
age (Darvill et al. 2000). However, a smaller 
Spanish study (Ribas-Fito et al. 2003) of 
92 infants 13 months of age found a signifi-
cant negative association between relatively 
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low cord serum DDE levels and cogni-
tive, psychomotor, and social development 
on the BSID and Griffith Scales of Infant 
Development. Similarly, a study of 230 
infants from Mexico found that maternal 
serum DDE levels were inversely associated 
with psychomotor development scores on the 
BSID at 3, 6, and 12 months (Torres-Sanchez 
et al. 2007). Using the Center for the Health 
Assessment of Mothers and Children of 
Salinas (CHAMACOS) cohort of Mexican-
American children, Eskenazi et al. (2006) also 
reported an inverse association of maternal 
serum DDE and psychomotor development 
at 6 and 12 but not at 24 months, and with 
mental development at 24 months. 
In a small study measuring visual evoked 
potentials (VEPs) in 12-month-olds (Riva 
et al. 2004), wave latency VEPs at 15 min 
were significantly related to the colostral levels 
of both DDT and DDE, and wave latency 
VEPs at 60 min were related to levels of DDT. 
However, findings were no longer statistically 
significant after authors controlled for the 
plasma levels of long-chain poly unsaturated 
fatty acids, thought to be one of the beneficial 
components of breast milk for brain devel-
opment. The authors concluded that breast-
feeding in itself may exert a protective effect 
against contaminants in human milk.
Only two studies have examined the rela-
tionship of DDT levels and cognitive func-
tioning. Increased maternal serum DDT 
levels were associated with poorer psychomo-
tor development at 6, 12, and 24 months and 
mental development at 12 and 24 months 
in the CHAMACOS cohort (Eskenazi et al. 
2006). Breast-feeding did not have a negative 
relationship with mental development in the 
group with the highest maternal DDT levels. 
In another study, cord serum DDT levels 
were also found to be associated with poorer 
performance in general cognitive, memory, 
quantitative, verbal, and executive function 
domains of the MCSA in 4- and 5-year-old 
children in Spain (Ribas-Fito et al. 2006b).
These studies suggest that DDT, and 
less so DDE, may be associated with neuro-
develop mental deficits. In addition, breast-
feeding may modulate some of the negative 
effects of DDT, but this needs to be examined 
when exposure is high such as in communities 
where indoor residual spraying is occurring. 
Follow-up studies of these populations are 
needed to verify whether these developmental 
deficits persist.
Evidence for Other Health Effects
Although thyroid hormones are essential for 
normal brain development (Dunn 1993), 
studies suggest that DDE, and possibly DDT, 
may depress triiodothyronine (T3) and/or thy-
roxine (T4) in maternal, cord, and preschool 
children’s blood (Abdelouahab et al. 2008; 
Alvarez-Pedrerol et al. 2008; Asawasinsopon 
et al. 2006; Maervoet et al. 2007; Takser et al. 
2005) but not entirely consistently (Chevrier 
et al. 2008). Higher DDT levels were also 
found in cases of congenital hypothyroidism 
relative to controls (Nagayama et al. 2007a). 
Results from studies conducted in men and 
nonpregnant women have generally been 
inconsistent. Two of these studies reported 
a positive association between serum DDE 
and thyroid-stimulating hormone (TSH) 
concentrations (Meeker et al. 2007; Rylander 
et al. 2006), one found a positive correla-
tion between DDE and total T3 (Langer 
et al. 2007a), whereas other studies found no 
associations between DDE and TSH (Langer 
et al. 2005, 2006, 2007a, 2007b; Turyk et al. 
2006), total T3 or the free T4 index (Turyk 
et al. 2006).
DDT and particularly DDE have dem-
onstrated the potential for modulating the 
human immune response as measured by mul-
tiple markers such as interleukin-4 (Daniel 
et al. 2002) and interleukin-13 (Brooks et al. 
2007), plasma levels of type 1 (interferon-γ) 
response to mitogen in nursing mothers, white 
blood cell counts, and various lymphocyte 
phenotypes (Nagayama et al. 2007b; Noakes 
et al. 2006; Vine et al. 2001), and immuno-
globulin (Ig) A, G, and E levels (Cooper et al. 
2004; Karmaus et al. 2005a). Associations 
with immune system–related conditions such 
as aplastic anemia (with DDT but not DDE) 
(Ahamed et al. 2006; Issaragrisil et al. 2006), 
asthma (with DDE) (Karmaus et al. 2001; 
Sunyer et al. 2005), otitis media (with DDE) 
(Dallaire et al. 2004), and farmer’s lung (with 
technical DDT use) (Hoppin et al. 2007) were 
also reported. In children, one cross- sectional 
study of German schoolchildren found 
that DDE levels in blood were associated 
with increased IgE blood levels and asthma 
(Karmaus et al. 2001). A longitudinal study of 
405 Spanish children confirmed the associa-
tion between DDE exposure and asthma, but 
found that DDE was not associated with IgE 
levels (Sunyer et al. 2005). Additional research 
is needed to understand the effects of DDT/
DDE on the immune system and associated 
diseases, especially because DDT is used in 
areas where there are often high rates of HIV.
Conclusions
The use of DDT historically may have helped 
prevent millions of infections and deaths from 
insect-borne diseases. Based on recent stud-
ies, we conclude that humans are exposed to 
DDT and DDE, that indoor residual spray-
ing can result in substantial exposure, and 
that DDT may pose a risk for human popula-
tions. However, few studies have measured 
body burdens of both DDE and DDT, and 
studies have rarely investigated the effects of 
DDT/DDE exposure at levels observed in 
populations exposed through indoor residual 
spraying. Furthermore, information on expo-
sure to DDT/DDE during critical periods is 
limited for outcomes such as cancer.
We are concerned about the health of 
children and adults given the persistence of 
DDT and its active metabolites in the envi-
ronment and in the body, and we are par-
ticularly concerned about the potential effects 
of continued DDT use on future genera-
tions. We recognize the serious implications 
of restricting DDT use given that an esti-
mated 880,000 people die each year from 
malaria, most of whom are < 5 years of age 
(WHO 2008). Given our continually deepen-
ing understanding of the effects of DDT use 
on humans, we ask global policy makers to 
consider the following issues:
•	In	the	United States, individuals have been 
exposed to DDT by working in occupa-
tional settings and by living in proximity 
to DDT manufacturing facilities. State and 
federal agencies should monitor levels of 
contaminants in residents near Superfund 
sites (e.g., Pine River/Velsicol Chemical 
Corp. Michigan Superfund site) and con-
duct health effects studies if biomonitoring 
indicates persistently elevated levels of DDT 
or DDE.
•	Few	studies	of	health	outcomes	have	been	
conducted in populations where indoor 
residual spraying with DDT is occurring. 
These populations likely have much higher 
exposures to DDT and may differ from those 
previously studied in ways that might affect 
susceptibility (e.g., genetics, diet, health sta-
tus, and social class). Research is needed to 
determine the exposure and health risks asso-
ciated with DDT used for indoor residual 
spraying in the relevant communities.
•	Children,	pregnant	women,	and	those	who	
are immunocompromised may be most at 
risk for the effects of DDT. People in many 
malaria-endemic areas where DDT is being 
used also have high rates of HIV/AIDS 
infection.
•	Breast-feeding is the best form of nutrition 
for infants and is recommended up to at 
least 1 year of age by the American Academy 
of Pediatrics (2005). In some African coun-
tries, women may breast-feed for up to 
2 years. However, because of the lipophilic 
nature of DDT/DDE, breast milk is a major 
route of DDT/DDE exposure to infants. 
Significant public health consequences could 
ensue should breast-feeding be discouraged 
as a result of high DDT contamination.
•	DDT	may	be	a	valuable	short-term	approach	
for controlling malaria, but measures should 
be taken to reduce human exposure to this 
pesticide. DDT exposure could conceiv-
ably be reduced through strict adherence to 
indoor residual spraying guidelines, better 
education of communities and applicators 
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regarding the potential hazards of DDT 
exposure, improved application methods and 
formulations, and a better understanding of 
the determinants of exposure.
•	New	methods	of	vector	control	should	be	
developed and rigorously tested considering 
local differences such as in vectors, parasites, 
ecology, and culture. As is the case for DDT, 
new methods for vector control should be 
evaluated not only for their effectiveness, but 
also for their potential adverse effects on the 
environment and populations, including to 
susceptible subpopulations such as those who 
are immunocompromised and malnourished. 
For example, pyrethroids have been substi-
tuted for DDT in indoor residual spraying in 
some locations, yet there is little information 
on their effects to human health.
Current evidence on DDT exposure to 
human populations and on its potential health 
effects support the Stockholm Convention on 
Persistent Organic Pollutants, which empha-
sizes that DDT should be used with cau-
tion, only when needed, and when no other 
effective, safe, and affordable alternatives are 
locally available. Under the convention, each 
country currently using DDT is required to 
provide an implementation and management 
plan to limit the use of DDT to disease vec-
tor control and to reduce reliance on DDT. 
Countries should be assisted so that they can 
ultimately rely on other sustainable methods, 
techniques, and strategies for malaria control. 
Given the paucity of data in populations who 
are currently potentially exposed to high lev-
els of DDT, we urge the global community 
to monitor exposure to DDT and to evaluate 
its potential health impacts both in malaria-
endemic regions of the world and in locations 
where DDT use has been historically high, 
such as the Pine River Superfund site.
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